tiprankstipranks
Trending News
More News >
Ironwood Pharmaceuticals (IRWD)
:IRWD
US Market

Ironwood Pharma (IRWD) Ratios

Compare
289 Followers

Ironwood Pharma Ratios

IRWD's free cash flow for Q3 2024 was $1.00. For the 2024 fiscal year, IRWD's free cash flow was decreased by $ and operating cash flow was $0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.84 30.58 4.61 15.16 7.50
Quick Ratio
0.84 30.53 4.60 15.16 7.48
Cash Ratio
0.33 25.71 3.84 11.08 4.33
Solvency Ratio
-1.22 0.39 1.02 0.22 -0.02
Operating Cash Flow Ratio
0.66 10.73 1.62 5.16 0.26
Short-Term Operating Cash Flow Coverage
0.92 89.32 2.24 53.98 9.36
Net Current Asset Value
$ -584.08M$ 332.49M$ 224.21M$ -759.00K$ -189.15M
Leverage Ratios
Debt-to-Assets Ratio
1.52 0.38 0.42 0.81 1.07
Debt-to-Equity Ratio
-2.07 0.64 0.79 7.24 -4.62
Debt-to-Capital Ratio
1.94 0.39 0.44 0.88 1.28
Long-Term Debt-to-Capital Ratio
3.28 0.38 0.36 0.87 1.28
Financial Leverage Ratio
-1.36 1.69 1.86 8.93 -4.32
Debt Service Coverage Ratio
-4.56 17.26 3.79 4.27 0.71
Interest Coverage Ratio
-43.71 32.95 7.46 4.85 3.28
Debt to Market Cap
0.39 0.21 0.24 0.24 0.21
Interest Debt Per Share
4.74 2.74 3.12 3.03 3.00
Net Debt to EBITDA
-0.67 -0.92 -0.62 0.64 2.51
Profitability Margins
Gross Profit Margin
76.33%99.65%99.63%99.19%94.43%
EBIT Margin
-209.25%63.33%56.03%35.51%22.30%
EBITDA Margin
-208.90%63.67%56.39%36.43%23.60%
Operating Profit Margin
-213.54%60.97%56.13%36.70%28.04%
Pretax Profit Margin
-214.14%61.48%48.50%27.95%13.76%
Net Profit Margin
-226.37%42.64%127.72%27.26%-3.57%
Continuous Operations Profit Margin
-233.00%42.64%127.72%27.26%13.76%
Net Income Per EBT
105.71%69.35%263.36%97.53%-25.98%
EBT Per EBIT
100.28%100.83%86.39%76.16%49.07%
Return on Assets (ROA)
-212.76%15.91%46.89%18.99%-3.80%
Return on Equity (ROE)
289.42%26.83%87.22%169.50%16.42%
Return on Capital Employed (ROCE)
-484.91%23.29%24.06%27.15%33.20%
Return on Invested Capital (ROIC)
-258.69%16.06%56.36%26.17%-8.57%
Return on Tangible Assets
-214.43%15.69%45.90%19.01%-3.81%
Earnings Yield
-56.36%9.15%27.93%5.85%-0.74%
Efficiency Ratios
Receivables Turnover
3.43 3.56 3.63 3.18 3.65
Payables Turnover
13.38 2.94 1.63 4.74 4.35
Inventory Turnover
0.00 1.13 1.22 3.14M 36.84
Fixed Asset Turnover
24.36 20.22 18.05 15.27 14.20
Asset Turnover
0.94 0.37 0.37 0.70 1.06
Working Capital Turnover Ratio
1.24 0.61 0.79 1.07 2.08
Cash Conversion Cycle
79.18 300.07 176.10 37.71 25.91
Days of Sales Outstanding
106.45 102.64 100.60 114.65 99.89
Days of Inventory Outstanding
0.00 321.76 299.57 <0.01 9.91
Days of Payables Outstanding
27.27 124.33 224.08 76.93 83.89
Operating Cycle
106.45 424.39 400.18 114.65 109.80
Cash Flow Ratios
Operating Cash Flow Per Share
1.18 1.77 1.61 1.06 0.07
Free Cash Flow Per Share
1.18 1.77 1.61 1.05 0.02
CapEx Per Share
<0.01 <0.01 <0.01 0.01 0.05
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 0.99 0.33
Dividend Paid and CapEx Coverage Ratio
671.89 2.01K 988.28 91.66 1.49
Capital Expenditure Coverage Ratio
671.89 2.01K 988.28 91.66 1.49
Operating Cash Flow Coverage Ratio
0.26 0.66 0.55 0.37 0.02
Operating Cash Flow to Sales Ratio
0.41 0.67 0.63 0.43 0.03
Free Cash Flow Yield
10.30%14.31%13.83%9.20%0.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.77 10.93 3.58 17.10 -135.61
Price-to-Sales (P/S) Ratio
4.02 4.66 4.57 4.66 4.85
Price-to-Book (P/B) Ratio
-5.13 2.93 3.12 28.99 -22.27
Price-to-Free Cash Flow (P/FCF) Ratio
9.71 6.99 7.23 10.87 587.29
Price-to-Operating Cash Flow Ratio
9.69 6.99 7.22 10.76 193.63
Price-to-Earnings Growth (PEG) Ratio
<0.01 -0.17 <0.01 -0.02 1.43
Price-to-Fair Value
-5.13 2.93 3.12 28.99 -22.27
Enterprise Value Multiple
-2.60 6.40 7.49 13.44 23.05
EV to EBITDA
-2.60 6.40 7.49 13.44 23.05
EV to Sales
5.42 4.07 4.22 4.90 5.44
EV to Free Cash Flow
13.11 6.11 6.68 11.42 659.18
EV to Operating Cash Flow
13.09 6.11 6.67 11.30 217.33
Tangible Book Value Per Share
-2.25 4.23 3.73 0.39 -0.60
Shareholders’ Equity Per Share
-2.23 4.23 3.73 0.39 -0.60
Tax and Other Ratios
Effective Tax Rate
-0.09 0.31 -1.63 0.02 1.26
Revenue Per Share
2.85 2.66 2.55 2.44 2.75
Net Income Per Share
-6.45 1.13 3.26 0.67 -0.10
Tax Burden
1.06 0.69 2.63 0.98 -0.26
Interest Burden
1.02 0.97 0.87 0.79 0.62
Research & Development to Revenue
0.26 0.11 0.17 0.23 0.27
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.07 0.07 0.05 0.08 0.07
Income Quality
-0.18 1.56 0.50 1.59 0.50
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis